Initiation of antiretroviral therapy in the HIV patient from a clinical case
DOI:
https://doi.org/10.32818/reccmi.a5n1a14Keywords:
HIV, pneumoniae, pneumocystis, antiretroviral therapy highly active.Abstract
Nowadays HIV infection has become a potentially treatable disease, although transmission and new diagnosis rates remain high. The majority of patients reach undetectable viral replication rates and have a life expectancy similar to normal population. We present the case of a patient which was admitted to the hospital with the diagnosis of pneumonia caused by Pneumocystis jirovecii and was later diagnosed with HIV infection. According to the latest evidence, early initiation of antiretroviral therapy is the most beneficial and recommended management for patients with HIV diagnosis, not only because of benefits for the patient, but to reduce transmission.
Downloads
Metrics
References
Panel de Expertos de GeSIDA y Plan Nacional sobre el Sida. Documento de consenso de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2020). Disponible en: https://gesida-seimc.org/category/guias-clinicas/borradores.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. Disponible en: https://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (último acceso: 13 de febrero de 2020).
Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Correction: initiating antiretroviral therapy for HIV, at a patient's first clinic visit: The RapIT Randomized Controlled Trial. PLoS Med. 2016; 13(6): e1002050. https://doi.org/10.1371/journal.pmed.1002050.
Koenig SP, Dorvil N, Dévieux JG, Hedt-Gauthier BL, Riviere C, Faustin M, et al. Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial. PLoS Med. 2017; 14(7): e1002357. https://doi.org/10.1371/journal.pmed.1002357.
Promer K, Karris MY. Current treatment options for HIV elite controllers: a review. Curr Treat Options Infect Dis. 2018; 10(2): 302-309. https://doi.org/10.1007/s40506-018-0158-8.
Update of recommendations on first and second-line antiretroviral regimens. Geneva, Switzerland. World Health Organization, 2019 (WHO/CDS/ HIV/19.15). Licence: CC BY-NC-SA 3.0 IGO. Disponible en: https://www.who.int/hiv/pub/arv/arv-update-2019-policy/en (último acceso: marzo 2020).
European AIDS Clinical Society (EACS). José Arribas, Catia Marzolini, Patrick Mallon, Andri Rauch, Ole Kirk Manuel Battegay and Lene Ryom. European AIDS Clínical Society Guidelines. Version 10.0. Nov 2019. Disponible en: https://www.eacsociety.org/files/2019_guidelines-10.0_final.pdf (último acceso: marzo 2020).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Fernando Maroto-Piñeiro, Antonio Ocampo-Hermida, Alexandre Pérez-González, Javier de-la-Fuente-Aguado
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
